Therefore, patients with craniopharyngioma and hypothalamic damage may present either with an oxytocin-synthesising deficiency, and/or a deficit in oxytocin section if axonal projection routes are disrupted (Gebert et al., 2018). This evidence concerns the gene OXT and craniopharyngioma.